Largest one day declines
The 50 largest one day percentage moves lower recorded at the latest close. The largest moves were ALK-B.CO at −2.5% and EMEIS.PA at −1.9%. By size, the list splits into 14 mega cap and 36 mid cap listings.
Switch view
All stocks50 of 23,178 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1D return | 1Y return |
|---|---|---|---|---|---|
| ALK-B.CO | ALK-Abelló A/S | $7.26B | Mid cap | −2.52% | +5.09% |
| EMEIS.PA | emeis Société anonyme | $2.55B | Mid cap | −1.92% | +10.93% |
| ASKER.ST | Asker Healthcare Group AB (publ) | $2.99B | Mid cap | −1.84% | −24.65% |
| AFX.DE | Carl Zeiss Meditec AG | $3.19B | Mid cap | −1.18% | −24.83% |
| ABL.DE | Abbott Laboratories | $200.44B | Mega cap | −1.06% | −10.02% |
| DEMANT.CO | Demant A/S | $9.36B | Mid cap | −0.84% | +17.12% |
| GETI-B.ST | Getinge AB (publ) | $7.01B | Mid cap | −0.69% | +20.89% |
| FIE.DE | Fielmann Group AG | $3.79B | Mid cap | −0.38% | −27.31% |
| ALIF-B.ST | AddLife AB (publ) | $2.08B | Mid cap | −0.06% | −7.20% |
| B72.DE | AtaiBeckley Inc. | $2.79B | Mid cap | 0.00% | +59.69% |
| BBZA.DE | BB Biotech AG | $3.87B | Mid cap | 0.00% | +7.22% |
| KRK.WA | Krka, d. d. | $9.20B | Mid cap | 0.00% | +30.59% |
| VIRP.PA | Virbac SA | $3.24B | Mid cap | 0.00% | −2.08% |
| WDH1.DE | Demant A/S | $9.33B | Mid cap | 0.00% | −5.53% |
| SECT-B.ST | Sectra AB (publ) | $5.63B | Mid cap | +0.15% | −17.02% |
| AMBU-B.CO | Ambu A/S | $2.69B | Mid cap | +0.19% | −19.13% |
| CTEC.L | Convatec Group PLC | $6.01B | Mid cap | +0.35% | −1.95% |
| HIK.L | Hikma Pharmaceuticals PLC | $4.61B | Mid cap | +0.43% | −9.62% |
| 1SXP.DE | SCHOTT Pharma AG & Co. KGaA | $4.08B | Mid cap | +0.44% | +1.26% |
| GNS.L | Genus plc | $2.08B | Mid cap | +0.44% | −12.94% |
| DRW3.DE | Drägerwerk AG & Co. KGaA | $2.45B | Mid cap | +0.54% | +70.53% |
| HCM.L | HUTCHMED (China) Limited | $2.16B | Mid cap | +0.56% | −18.08% |
| MCOV-B.ST | Medicover AB (publ) | $3.85B | Mid cap | +0.62% | −8.20% |
| EKTA-B.ST | Elekta AB (publ) | $2.20B | Mid cap | +0.81% | +26.10% |
| QIA.DE | Qiagen N.V. | $8.99B | Mid cap | +0.84% | −6.73% |
| CAMX.ST | Camurus AB (publ) | $3.79B | Mid cap | +0.90% | −15.35% |
| NOT.DE | Novartis AG | $300.14B | Mega cap | +0.92% | +28.89% |
| 4AB.DE | AbbVie Inc. | $471.29B | Mega cap | +1.02% | +32.34% |
| BV3.DE | Bavarian Nordic A/S | $2.55B | Mid cap | +1.04% | +15.65% |
| AMG.DE | Amgen Inc. | $237.76B | Mega cap | +1.08% | +60.12% |
| RHO.DE | Roche Holding AG | $370.84B | Mega cap | +1.30% | +41.42% |
| 22Z.DE | Zealand Pharma A/S | $3.37B | Mid cap | +1.33% | −28.16% |
| TN8.DE | Thermo Fisher Scientific Inc. | $234.00B | Mega cap | +1.44% | +29.67% |
| OBCK.DE | Ottobock SE & Co. KGaA | $4.40B | Mid cap | +1.51% | +0.68% |
| GN.CO | GN Store Nord A/S | $2.13B | Mid cap | +1.52% | −18.50% |
| LLY.DE | Eli Lilly and Company | $1.07T | Mega cap | +1.60% | +73.55% |
| JNJ.DE | Johnson & Johnson | $651.71B | Mega cap | +1.67% | +58.93% |
| NVO.WA | Novo Nordisk A/S | $212.23B | Mega cap | +2.02% | −9.22% |
| 6MK.DE | Merck & Co., Inc. | $379.64B | Mega cap | +2.23% | +91.49% |
| BAVA.CO | Bavarian Nordic A/S | $2.51B | Mid cap | +2.44% | −7.97% |
| AZN.ST | AstraZeneca PLC | $258.56B | Mega cap | +2.61% | +6.22% |
| HLUN-B.CO | H. Lundbeck A/S | $6.47B | Mid cap | +2.74% | +8.99% |
| NOVO-B.CO | Novo Nordisk A/S | $210.20B | Mega cap | +2.86% | −11.26% |
| AZN.L | AstraZeneca PLC | $264.05B | Mega cap | +3.02% | +5.65% |
| HLUN-A.CO | H. Lundbeck A/S | $6.40B | Mid cap | +3.05% | +29.71% |
| NOV.DE | Novo Nordisk A/S | $209.27B | Mega cap | +3.49% | +15.22% |
| BIOA-B.ST | BioArctic AB (publ) | $3.00B | Mid cap | +4.61% | +12.31% |
| NANO.PA | Nanobiotix S.A. | $2.05B | Mid cap | +4.69% | +358.21% |
| DMP.DE | Dermapharm Holding SE | $2.31B | Mid cap | +5.53% | +27.27% |
| ZEAL.CO | Zealand Pharma A/S | $3.34B | Mid cap | +5.66% | −25.94% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.
Micro and small cap listings are left out, so the list describes the market rather than thin trading, as are moves beyond 1,000% in a session, which are corporate actions the price series has not been restated for. This is a description of one day of price movement, nothing more. It says nothing about any company behind it.